Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10017)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
KMT2D
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Polyunsaturated fatty acid lipoxygenase ALOX12 (ALOX12) [Driver]
| In total 1 item(s) under this target | |||||
| Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
| Target for Ferroptosis | Driver | ||||
| Responsed Disease | Health | ICD-11: N.A. | |||
| Pathway Response | Fatty acid metabolism | hsa01212 | |||
| Ferroptosis | hsa04216 | ||||
| Cell Process | Cell ferroptosis | ||||
| Cell proliferation | |||||
| Cell differentiation | |||||
In Vitro Model |
NHEK/SV3 cells | Normal | Homo sapiens | CVCL_9Q50 | |
| 3T3-J2 cells | Normal | Mus musculus | CVCL_W667 | ||
| In Vivo Model |
All animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania. Mice were maintained on a mixed C57BL/6 background on a standard light-dark cycle. Mice carrying Mll4SET floxed alleles, Mll3SET floxed alleles, or a combination of both of these were crossed with Krt14-Cre transgenic mice.
Click to Show/Hide
|
||||
| Response regulation | MLL4 (KMT2D) deficiency profoundly alters epidermal gene expression and uniquely rewires the expression of key genes and markers of ferroptosis (Alox12, Alox12b, and Aloxe3). | ||||
Hydroperoxide isomerase ALOXE3 (ALOXE3) [Driver]
| In total 1 item(s) under this target | |||||
| Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
| Target for Ferroptosis | Driver | ||||
| Responsed Disease | Health | ICD-11: N.A. | |||
| Pathway Response | Fatty acid metabolism | hsa01212 | |||
| Ferroptosis | hsa04216 | ||||
| Cell Process | Cell ferroptosis | ||||
| Cell proliferation | |||||
| Cell differentiation | |||||
In Vitro Model |
NHEK/SV3 cells | Normal | Homo sapiens | CVCL_9Q50 | |
| 3T3-J2 cells | Normal | Mus musculus | CVCL_W667 | ||
| In Vivo Model |
All animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania. Mice were maintained on a mixed C57BL/6 background on a standard light-dark cycle. Mice carrying Mll4SET floxed alleles, Mll3SET floxed alleles, or a combination of both of these were crossed with Krt14-Cre transgenic mice.
Click to Show/Hide
|
||||
| Response regulation | MLL4 (KMT2D) deficiency profoundly alters epidermal gene expression and uniquely rewires the expression of key genes and markers of ferroptosis (Alox12, Alox12b, and Aloxe3). | ||||
Arachidonate 12-lipoxygenase, 12R-type (ALOX12B) [Driver]
| In total 1 item(s) under this target | |||||
| Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
| Target for Ferroptosis | Driver | ||||
| Responsed Disease | Health | ICD-11: N.A. | |||
| Pathway Response | Fatty acid metabolism | hsa01212 | |||
| Ferroptosis | hsa04216 | ||||
| Cell Process | Cell ferroptosis | ||||
| Cell proliferation | |||||
| Cell differentiation | |||||
In Vitro Model |
NHEK/SV3 cells | Normal | Homo sapiens | CVCL_9Q50 | |
| 3T3-J2 cells | Normal | Mus musculus | CVCL_W667 | ||
| In Vivo Model |
All animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania. Mice were maintained on a mixed C57BL/6 background on a standard light-dark cycle. Mice carrying Mll4SET floxed alleles, Mll3SET floxed alleles, or a combination of both of these were crossed with Krt14-Cre transgenic mice.
Click to Show/Hide
|
||||
| Response regulation | MLL4 (KMT2D) deficiency profoundly alters epidermal gene expression and uniquely rewires the expression of key genes and markers of ferroptosis (Alox12, Alox12b, and Aloxe3). | ||||
Health [ICD-11: N.A.]
| In total 3 item(s) under this disease | |||||
| Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
| Target Regulator | Histone-lysine N-methyltransferase 2D (KMT2D) | Protein coding | |||
| Pathway Response | Fatty acid metabolism | hsa01212 | |||
| Ferroptosis | hsa04216 | ||||
| Cell Process | Cell ferroptosis | ||||
| Cell proliferation | |||||
| Cell differentiation | |||||
In Vitro Model |
NHEK/SV3 cells | Normal | Homo sapiens | CVCL_9Q50 | |
| 3T3-J2 cells | Normal | Mus musculus | CVCL_W667 | ||
| In Vivo Model |
All animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania. Mice were maintained on a mixed C57BL/6 background on a standard light-dark cycle. Mice carrying Mll4SET floxed alleles, Mll3SET floxed alleles, or a combination of both of these were crossed with Krt14-Cre transgenic mice.
Click to Show/Hide
|
||||
| Response regulation | MLL4 (KMT2D) deficiency profoundly alters epidermal gene expression and uniquely rewires the expression of key genes and markers of ferroptosis (Alox12, Alox12b, and Aloxe3). | ||||
| Experiment 2 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
| Target Regulator | Histone-lysine N-methyltransferase 2D (KMT2D) | Protein coding | |||
| Pathway Response | Fatty acid metabolism | hsa01212 | |||
| Ferroptosis | hsa04216 | ||||
| Cell Process | Cell ferroptosis | ||||
| Cell proliferation | |||||
| Cell differentiation | |||||
In Vitro Model |
NHEK/SV3 cells | Normal | Homo sapiens | CVCL_9Q50 | |
| 3T3-J2 cells | Normal | Mus musculus | CVCL_W667 | ||
| In Vivo Model |
All animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania. Mice were maintained on a mixed C57BL/6 background on a standard light-dark cycle. Mice carrying Mll4SET floxed alleles, Mll3SET floxed alleles, or a combination of both of these were crossed with Krt14-Cre transgenic mice.
Click to Show/Hide
|
||||
| Response regulation | MLL4 (KMT2D) deficiency profoundly alters epidermal gene expression and uniquely rewires the expression of key genes and markers of ferroptosis (Alox12, Alox12b, and Aloxe3). | ||||
| Experiment 3 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
| Target Regulator | Histone-lysine N-methyltransferase 2D (KMT2D) | Protein coding | |||
| Pathway Response | Fatty acid metabolism | hsa01212 | |||
| Ferroptosis | hsa04216 | ||||
| Cell Process | Cell ferroptosis | ||||
| Cell proliferation | |||||
| Cell differentiation | |||||
In Vitro Model |
NHEK/SV3 cells | Normal | Homo sapiens | CVCL_9Q50 | |
| 3T3-J2 cells | Normal | Mus musculus | CVCL_W667 | ||
| In Vivo Model |
All animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania. Mice were maintained on a mixed C57BL/6 background on a standard light-dark cycle. Mice carrying Mll4SET floxed alleles, Mll3SET floxed alleles, or a combination of both of these were crossed with Krt14-Cre transgenic mice.
Click to Show/Hide
|
||||
| Response regulation | MLL4 (KMT2D) deficiency profoundly alters epidermal gene expression and uniquely rewires the expression of key genes and markers of ferroptosis (Alox12, Alox12b, and Aloxe3). | ||||
